Form 4: Delcath Systems Director Aharon Gil Acquires 400,000 Shares Through Warrant Exercise

Director Aharon Gil reports the acquisition of 400,000 common shares of Delcath Systems through the exercise of warrants.

Summary

• On May 5, 2025, Aharon Gil, a director of Delcath Systems, Inc., acquired 400,000 common shares by exercising warrants at a price of $10 per share.
• Following the transaction, Mr. Gil beneficially owns 3,413,468 shares indirectly through Rosalind Advisors Inc., the advisor to the Rosalind Funds.
• The shares are held by Rosalind Master Fund L.P. (1,565,844 shares), Rosalind Opportunities Fund I L.P. (1,734,545 shares), Steven Salamon (82,197 shares), and Gilad Aharon (30,882 shares).

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The director's purchase could be seen as positive, but without further context, it's difficult to gauge the overall impact.

Positives

• The acquisition of shares by a director could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in the biotech industry. Monitoring such transactions can provide insights into management's sentiment about the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Delcath Systems, DCTH, Aharon Gil, Rosalind Advisors, Beneficial Ownership, Form 4, Warrant Exercise, Director